Literature DB >> 19435612

Failures to reconsolidate memory in a mouse model of Alzheimer's disease.

Masuo Ohno1.   

Abstract

Previous studies have demonstrated that the formation of spatial, contextual and trace conditioning memories are impaired in animal models of Alzheimer's disease (AD), consistent with the observations that the first sign of cognitive decline in AD includes difficulties in the acquisition of new information or memory formation. Evidence is accumulating that memory retrieval is a dynamic process in which stored information becomes labile again and needs to be restabilized. However, it is poorly understood how this process referred to as memory reconsolidation is affected in animal models of AD. The present study was designed to use contextual fear conditioning to compare the changes in memory formation and subsequent reconsolidation processes in transgenic mice that overexpress human APP and PS1 harboring five familial AD mutations (5XFAD model). The results clearly demonstrate that cognitive dysfunction starts to occur primarily as reduced levels of contextual learning or memory formation in 5XFAD mice, but it is exacerbated by additional retrieval-dependent retrograde amnesia due to deficient reconsolidation as disease further develops.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19435612      PMCID: PMC2772829          DOI: 10.1016/j.nlm.2009.05.001

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  40 in total

Review 1.  Contextual fear, gestalt memories, and the hippocampus.

Authors:  M S Fanselow
Journal:  Behav Brain Res       Date:  2000-06-01       Impact factor: 3.332

Review 2.  Reconsolidation: the advantage of being refocused.

Authors:  Yadin Dudai
Journal:  Curr Opin Neurobiol       Date:  2006-03-24       Impact factor: 6.627

Review 3.  Molecular mechanisms of memory reconsolidation.

Authors:  Natalie C Tronson; Jane R Taylor
Journal:  Nat Rev Neurosci       Date:  2007-04       Impact factor: 34.870

4.  Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

Authors:  Holly Oakley; Sarah L Cole; Sreemathi Logan; Erika Maus; Pei Shao; Jeffery Craft; Angela Guillozet-Bongaarts; Masuo Ohno; John Disterhoft; Linda Van Eldik; Robert Berry; Robert Vassar
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

Review 5.  A decade of modeling Alzheimer's disease in transgenic mice.

Authors:  Eileen McGowan; Jason Eriksen; Michael Hutton
Journal:  Trends Genet       Date:  2006-03-29       Impact factor: 11.639

6.  Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.

Authors:  Zhi-Liang Wu; John R Ciallella; Dorothy G Flood; Teresa M O'Kane; Donna Bozyczko-Coyne; Mary J Savage
Journal:  Neurobiol Aging       Date:  2005-05-31       Impact factor: 4.673

7.  Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.

Authors:  Masuo Ohno; Lei Chang; Wilbur Tseng; Holly Oakley; Martin Citron; William L Klein; Robert Vassar; John F Disterhoft
Journal:  Eur J Neurosci       Date:  2006-01       Impact factor: 3.386

8.  Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory.

Authors:  Bing Gong; Zixuan Cao; Ping Zheng; Ottavio V Vitolo; Shumin Liu; Agnieszka Staniszewski; Donna Moolman; Hong Zhang; Michael Shelanski; Ottavio Arancio
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

Review 9.  Genetic and pharmacological basis for therapeutic inhibition of beta- and gamma-secretases in mouse models of Alzheimer's memory deficits.

Authors:  Masuo Ohno
Journal:  Rev Neurosci       Date:  2006       Impact factor: 4.353

Review 10.  Plaques, tangles, and memory loss in mouse models of neurodegeneration.

Authors:  Jason L Eriksen; Christopher G Janus
Journal:  Behav Genet       Date:  2006-10-28       Impact factor: 2.805

View more
  39 in total

1.  5XFAD mice show early-onset gap encoding deficits in the auditory cortex.

Authors:  Aldis P Weible; Amanda J Stebritz; Michael Wehr
Journal:  Neurobiol Aging       Date:  2020-06-01       Impact factor: 4.673

2.  Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease.

Authors:  Charles Y Shao; Suzanne S Mirra; Hameetha B R Sait; Todd C Sacktor; Einar M Sigurdsson
Journal:  Acta Neuropathol       Date:  2011-06-01       Impact factor: 17.088

Review 3.  Mouse models of Alzheimer's disease.

Authors:  Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2011-11-28       Impact factor: 4.077

4.  Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.

Authors:  Pooneh Memar Ardestani; Andrew K Evans; Bitna Yi; Tiffany Nguyen; Laurence Coutellier; Mehrdad Shamloo
Journal:  Neuropharmacology       Date:  2017-01-13       Impact factor: 5.250

5.  Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.

Authors:  L Devi; M Ohno
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

Review 6.  Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.

Authors:  A Shepherd; S Tyebji; A J Hannan; E L Burrows
Journal:  J Mol Neurosci       Date:  2016-09-16       Impact factor: 3.444

7.  Parvalbumin-Positive Neuron Loss and Amyloid-β Deposits in the Frontal Cortex of Alzheimer's Disease-Related Mice.

Authors:  Farhan Ali; Stephanie L Baringer; Arianna Neal; Esther Y Choi; Alex C Kwan
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

8.  Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.

Authors:  Ryoichi Kimura; Latha Devi; Masuo Ohno
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

9.  Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice.

Authors:  Latha Devi; Masuo Ohno
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

10.  Evidence for Alzheimer's disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons.

Authors:  Krystina M Neuman; Elizabeth Molina-Campos; Timothy F Musial; Andrea L Price; Kwang-Jin Oh; Malerie L Wolke; Eric W Buss; Stephen W Scheff; Elliott J Mufson; Daniel A Nicholson
Journal:  Brain Struct Funct       Date:  2014-07-17       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.